In ovarian cancer, CSCs (CD133+/CD117+) were revealed to depend on OXPHOS instead of glycolysis, show concomitantly elevated ROS levels as well as mitochondrial membrane potential and have pro-tumorigenic features [224]. Here, KIT is linked to ovarian carcinoma.